InVivo Therapeutics Hldgs Corp (fka NVIVQ)

[pistol1p]

As Hound said, during the time between the RS and the enrollment of patients 3-5, and the uplist, you could see some buying opportunities. Not that we couldn't see patients enrolled this week.

I was please, however, that this was a 5% up day. Low volume today could have meant that we had some investors taking a wait as see approach to the RS before adding or jumping in.

The buying could resume at anytime, and that is the investors dilemma.